BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New scan could end guesswork: tumor or radiation damage?
Diagnosis Recruiting nowThis study tests a new type of PET scan (Ga68-PSMA) to see if it can tell the difference between a growing tumor and radiation scar in people with brain metastases from lung cancer, melanoma, or breast cancer. About 100 adults who have had radiation treatment will get the scan. T…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated May 26, 2026 12:10 UTC
-
Brain tumor patients may avoid seizures with common drug, new trial hopes
Prevention Recruiting nowThis study tests whether the seizure drug levetiracetam (Keppra) can prevent first-time seizures in people with brain metastases located in the motor cortex. About 150 adults who have never had a seizure will be randomly assigned to take the drug or receive usual care. The goal i…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ayal A. Aizer, MD • Aim: Prevention
Last updated May 15, 2026 11:54 UTC
-
Can Same-Day scans make brain radiation more precise?
Knowledge-focused Recruiting nowThis study looks at whether doing radiation planning and treatment on the same day can better target fast-growing brain tumors. About 60 adults with brain metastases from solid cancers will be randomly assigned to receive radiation with a very small or no extra safety margin. The…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ayal A. Aizer, MD • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC